Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Investment Securities: 2018-2025

Historic Gains from Investment Securities for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $55.9 million.

  • Verastem's Gains from Investment Securities rose 515.26% to $55.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year increase of 626.35%. This contributed to the annual value of $19.1 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Verastem's Gains from Investment Securities is $55.9 million, which was up 375.00% from -$20.3 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Gains from Investment Securities registered a high of $55.9 million during Q3 2025, and its lowest value of -$20.3 million during Q2 2025.
  • In the last 3 years, Verastem's Gains from Investment Securities had a median value of $2.2 million in 2024 and averaged $8.9 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 116,910.50% in 2022, then tumbled by 1,015.38% in 2025.
  • Verastem's Gains from Investment Securities (Quarterly) stood at -$1,000 in 2021, then surged by 116,910.50% to $1.2 million in 2022, then plummeted by 84.47% to $2.1 million in 2023, then slumped by 734.60% to $32.6 million in 2024, then soared by 515.26% to $55.9 million in 2025.
  • Its Gains from Investment Securities stands at $55.9 million for Q3 2025, versus -$20.3 million for Q2 2025 and $2.4 million for Q1 2025.